[Remote] MRD Clinical Account Executive - Midwest at Tempus

Minnesota, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Diagnostics, OncologyIndustries

Skills

Key technologies and capabilities for this role

Clinical salesBusiness developmentStakeholder engagementStrategic planningPartnership developmentMarket analysis

Questions & Answers

Common questions about this position

What qualifications are required for the MRD Clinical Account Executive role?

Candidates need a B.S. in life science, biology, business, or marketing (MBA preferred), 3+ years of direct account management experience in molecular diagnostics (MRD focus preferred), and a proven track record of revenue generation in diagnostics, pharma, or biotech.

What key skills are needed for this position?

Required skills include proven ability in consultative selling of molecular diagnostics, engaging executive stakeholders, understanding oncology reimbursement, strong communication and project management, knowledge of MRD testing, and proficiency in Microsoft Office and Salesforce.

Is this a remote position or does it require travel?

This information is not specified in the job description.

What is the salary or compensation for this role?

This information is not specified in the job description.

What makes a strong candidate for this MRD Clinical Account Executive position?

A strong candidate has 3+ years in molecular diagnostics with MRD experience, a track record of revenue generation, consultative selling skills, oncology reimbursement knowledge, and the ability to engage executives independently.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free